From edibles to cosmetics and skin care, the market for products containing cannabidiol (CBD) is surging. And after long being banned by the federal government, regulators are now rethinking their approach to CBD- and hemp-derived products. But the regulatory outlook is far from clear — in fact, significant risks remain, and retailers must do their homework before restocking their shelves with CBD products.
The latest edition of Marsh’s Taking Stock series looks at the regulatory landscape surrounding CBD products and provides advice for retail risk professionals who are considering entering this emerging market.
